Sage Journals: Discover world-class research

Open access

Research article

First published 2024-03-19

Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR,ALK and ROS1 tyrosine kinase inhibitors: An update

Joanna Moes-Sosnowska, Adam Szpechcinski, Joanna Chorostowska-Wynimko

Tumor Biology

Free access

Review article

First published 2016-4

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

Meghan Shea, Daniel B. Costa, Deepa Rangachari

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020-12

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

Mingming Hu, Tongmei Zhang, Yuan Yang [...]

The International Journal of Biological Markers

Retricted access

Research article

First published 2022-2

Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples

Aslıhan Gürün Kaya, Aydın Çiledağ, Serhat Erol [...]

Scottish Medical Journal

Open access

Review article

First published 2024

Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis

Jiayan Chen, Wanjun Lu, Mo Chen [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

Biomarker testing for personalized,first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective,multicenter,observational study (the BRAVE study)

Junichi Shimizu, Katsuhiro Masago, Haruhiro Saito [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Genetic Profiling of Non-Small Cell Lung Cancer in Moroccan Patients by Targeted Next-Generation Sequencing

Sara El Zaitouni, Abdelilah Laraqui, Meriem Ghaouti [...]

Technology in Cancer Research & Treatment

Open access

Case report

First published 2018

Crizotinib,an Effective Agent in ROS1 -Rearranged Adenocarcinoma of Lungs: A Case Report

Julie Mariam Joshua, Salima KD, Pavithran K [...]

Clinical Medicine Insights: Case Reports

Retricted access

Case report

First published 2021-6

68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report

Ozgur Tanriverdi, Mehmet L Tarimer, Ceren D Pak [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations

Nadia Ghazali, Jamie Feng, Katrina Hueniken [...]

Therapeutic Advances in Medical Oncology

Search results